Mordor Intelligence has published a new report on the prostate cancer market, offering a comprehensive analysis of trends, growth drivers, and future projections.

An oncologist believes more genetic testing could be among answers to improving the health of Bermudians. Kevin Hughes, ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a murkier story.

NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways ...

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

Prostate cancer is a type of cancer that affects men. It used to be common only in men over 60, but that's changing. Doctors ...

But what makes Tewari compelling is not just the scale of his achievement. It is the moral clarity with which he speaks about ...

Mesothelioma, a rare cancer that usually starts in the lining around the lungs, has long been thought of as a condition that affects older men—especially those who may have been exposed to asbestos ...

Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious ...